January 22, 2021acquire, acquisition, analysis, analytics, Aphria, Ayr, business, Business Analysis, california, CANADA, cannabis, capital, cbd, Columbia Care, compliance, consumer, COVID, COVID-19, cultivation, curaleaf, Depreciation, dispensary, EBITDA, extraction, Federal, finance, financial, financing strategies, government, Grassroot, growing, growth, Health, holdings, industry, Institutional, Interest, invest, investor, law, legal, legalization, legalize, legislation, Liberty, license, marijuana, market, medical, medicine, merge, merger, MSO, multi, operator, product, Quality, recreational, regulation, regulations, regulatory, retail, Sciences, Select, short, state, strategies, taxes, term, thc, Tilray, Verano Cannabis M&A in the Post-COVID Era After a slow start following a disappointing 2019, M&A in the cannabis space closed 2020 with a bang, with more than $600 […]